ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan eyes COVID antibody cocktail for homebound patients

Health ministry weighs care options outside hospitals amid bed shortage

The antibody treatment developed by U.S. company Regeneron was used to treat former President Trump.   © Reuters

TOKYO -- Japan's health ministry is working to approve at-home use of the COVID-19 antibody cocktail available to inpatients, as the country's surge in new cases forces many hospitals to reserve beds only for the sickest.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more